Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,855 | 109 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $269.56 | 21 | $0 (2020) |
| Novo Nordisk Inc | $236.86 | 13 | $0 (2020) |
| AbbVie, Inc. | $159.23 | 10 | $0 (2019) |
| Daiichi Sankyo Inc. | $155.30 | 8 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $149.45 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $143.53 | 6 | $0 (2019) |
| PFIZER INC. | $115.21 | 8 | $0 (2020) |
| Amgen Inc. | $80.56 | 5 | $0 (2019) |
| Abbott Laboratories | $69.57 | 2 | $0 (2019) |
| Amarin Pharma Inc. | $56.91 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.47 | 2 | Inspire Medical Systems, Inc. ($22.36) |
| 2023 | $30.50 | 2 | AstraZeneca Pharmaceuticals LP ($30.50) |
| 2020 | $131.25 | 8 | PFIZER INC. ($40.53) |
| 2019 | $732.48 | 42 | AbbVie, Inc. ($136.69) |
| 2018 | $387.78 | 21 | Novo Nordisk Inc ($81.84) |
| 2017 | $531.88 | 34 | Merck Sharp & Dohme Corporation ($112.75) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 02/24/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/14/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Anemia | ||||||
| 01/31/2020 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 01/24/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Cardiovascular | ||||||
| 01/21/2020 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: VACCINES | ||||||
| 01/14/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/03/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, STEGLATRO | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/10/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Neuroscience | ||||||
| 12/02/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $38.84 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/02/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/30/2019 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: VACCINES | ||||||
| 11/22/2019 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/08/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Neuroscience | ||||||
| 11/05/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Anemia | ||||||
| 11/01/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: VACCINE | ||||||
| 10/29/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $21.56 | General |
| 10/29/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $2.01 | General |
| 10/15/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 569 | 844 | $158,525 | $76,084 |
| 2022 | 7 | 564 | 804 | $147,334 | $74,570 |
| 2021 | 22 | 1,909 | 2,258 | $210,748 | $93,352 |
| 2020 | 28 | 2,419 | 3,121 | $246,759 | $94,489 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 366 | $95,160 | $36,831 | 38.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 150 | 150 | $30,750 | $21,720 | 70.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 192 | $27,264 | $12,760 | 46.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 43 | $2,838 | $2,717 | 95.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $1,457 | $1,428 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $372.00 | $334.18 | 89.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 20 | $460.00 | $263.20 | 57.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 14 | $224.00 | $30.80 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 315 | $81,900 | $32,169 | 39.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 149 | 149 | $30,545 | $22,373 | 73.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 201 | $28,542 | $14,371 | 50.4% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 54 | 54 | $3,888 | $3,701 | 95.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 56 | 56 | $1,736 | $1,701 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $345.00 | $159.50 | 46.2% |
| 90471 | Administration of vaccine | Office | 2022 | 12 | 14 | $378.00 | $94.78 | 25.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 304 | $68,360 | $28,177 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 175 | 175 | $28,855 | $26,251 | 91.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 206 | 311 | $43,708 | $19,583 | 44.8% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 48 | 48 | $3,456 | $3,124 | 90.4% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 11 | 11 | $4,400 | $2,644 | 60.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 113 | 120 | $6,000 | $2,016 | 33.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 139 | 147 | $7,350 | $1,968 | 26.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 163 | 190 | $10,450 | $1,607 | 15.4% |
| 80076 | Liver function blood test panel | Office | 2021 | 143 | 154 | $8,008 | $1,258 | 15.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 144 | 150 | $4,800 | $1,166 | 24.3% |
About Dr. Andrea Karp, MD
Dr. Andrea Karp, MD is a Internal Medicine healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790856433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrea Karp, MD has received a total of $1,855 in payments from pharmaceutical and medical device companies, with $41.47 received in 2024. These payments were reported across 109 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,855).
As a Medicare-enrolled provider, Karp has provided services to 5,461 Medicare beneficiaries, totaling 7,027 services with total Medicare billing of $338,495. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bethesda, MD
- Active Since 11/13/2006
- Last Updated 05/03/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790856433
Products in Payments
- INJECTAFER (Drug) $155.30
- JARDIANCE (Drug) $134.17
- JANUVIA (Drug) $130.41
- Victoza (Drug) $104.85
- Ozempic (Drug) $70.87
- Proclaim Family of SCS IPGs (Device) $69.57
- Synthroid (Drug) $67.62
- Aimovig (Biological) $64.81
- Vascepa (Drug) $56.91
- XARELTO (Drug) $56.64
- PNEUMOVAX 23 (Biological) $56.35
- SYMBICORT (Drug) $55.52
- PREVNAR - 13 (Biological) $53.19
- BREZTRI (Drug) $49.61
- ADVAIR (Drug) $47.35
- Tresiba (Drug) $47.00
- Algovita (Device) $41.00
- Edarbi (Drug) $40.74
- BEVESPI AEROSPHERE (Drug) $29.93
- NASCOBAL (Drug) $28.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bethesda
Dr. Jay Shapiro, M.d, M.D
Internal Medicine — Payments: $96,294
Sandeep Rahangdale, M.d, M.D
Internal Medicine — Payments: $42,379
Dr. Christopher Lettieri, Md, MD
Internal Medicine — Payments: $40,731
Dr. Mihail Zilbermint, M.d, M.D
Internal Medicine — Payments: $20,885
Dr. Thanh Hoang, D.o, D.O
Internal Medicine — Payments: $17,556
Dr. Scott Williams, Md, MD
Internal Medicine — Payments: $17,162